Australian Dairy Nutritionals Group (AU:AHF)
ASX:AHF
Top Page
Australian Dairy Nutritionals Group
(Sydney:AHF)
Select Model
Select Model
Rating:40Underperform
Price Target:
AU$0.02
▼(-40.00% Downside)
Action:ReiteratedDate:01/10/26
The score is primarily held down by weak financial performance: despite strong revenue growth, the company remains unprofitable with negative margins and cash flow challenges. Technicals also weigh on the score given a clear downtrend and negative MACD, with oversold signals providing only a modest offset. Valuation is difficult to support because the negative P/E reflects ongoing losses and there is no dividend yield data.
Positive Factors
Strong revenue growth
Sustained double-digit top-line growth (Fundamentals.RevenueGrowth ~44.25%) indicates expanding demand or successful distribution gains. Over 2–6 months this underpins scale advantages and supports future margin improvement if cost structure stabilises and sales mix continues to improve.
Negative Factors
Persistent negative margins
Negative gross and operating margins point to structural profitability issues: either pricing, input costs, or operational inefficiencies. Without consistent margin recovery, revenue growth may not translate to shareholder returns and long-term viability is at risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained double-digit top-line growth (Fundamentals.RevenueGrowth ~44.25%) indicates expanding demand or successful distribution gains. Over 2–6 months this underpins scale advantages and supports future margin improvement if cost structure stabilises and sales mix continues to improve.
Read all positive factors
Australian Dairy Nutritionals Group (AHF) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$26.02M
Dividend YieldN/A
Average Volume (3M)465.88K
Price to Earnings (P/E)―
Beta (1Y)0.40
Revenue Growth13.92%
EPS Growth36.28%
CountryAU
EmployeesN/A
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding867,208,800
10 Day Avg. Volume385,458
30 Day Avg. Volume465,878
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.33
Price to Sales (P/S)4.44
P/FCF Ratio-9.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Australian Dairy Nutritionals Group Business Overview & Revenue Model
Company Description
Australian Dairy Nutritionals Group operates as an integrated producer of dairy products in Australia. The company operates through Dairy Farms and Dairy Processing segments. The Dairy Farms segment owns and operates dairy farms and dairy livestoc...
How the Company Makes Money
null...
Australian Dairy Nutritionals Group Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
30
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.53M | 7.17M | 6.18M | 5.86M | 5.80M | 21.30M |
| Gross Profit | -1.10M | -1.42M | -2.15M | -288.23K | -4.36M | -3.27M |
| EBITDA | -4.54M | -4.30M | -6.26M | -5.95M | -1.29M | -5.34M |
| Net Income | -4.42M | -5.21M | -7.36M | -9.16M | -4.15M | -6.40M |
Balance Sheet | ||||||
| Total Assets | 24.17M | 25.09M | 30.35M | 36.24M | 44.60M | 43.11M |
| Cash, Cash Equivalents and Short-Term Investments | 809.01K | 2.69M | 6.13M | 2.01M | 2.43M | 6.23M |
| Total Debt | 200.85K | 48.45K | 2.25M | 1.04M | 1.09M | 6.49M |
| Total Liabilities | 2.02M | 1.44M | 3.62M | 2.72M | 4.65M | 9.12M |
| Stockholders Equity | 22.31M | 23.85M | 26.87M | 33.59M | 16.05M | 33.99M |
Cash Flow | ||||||
| Free Cash Flow | -3.65M | -3.46M | -4.72M | -7.91M | -6.90M | -7.11M |
| Operating Cash Flow | -3.24M | -3.28M | -4.44M | -7.05M | -3.80M | -2.03M |
| Investing Cash Flow | -245.46K | -47.59K | 6.73M | 6.18M | 3.10M | 1.07M |
| Financing Cash Flow | -184.50K | -94.51K | 1.80M | 449.98K | -3.07M | 796.49K |
Australian Dairy Nutritionals Group Technical Analysis
Positive
0.04
Price Trends
0.03
Positive
0.03
Negative
0.04
Negative
Market Momentum
>-0.01
Negative
56.31
Neutral
28.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHF, the sentiment is Positive. The current price of 0.04 is above the 20-day moving average (MA) of 0.03, above the 50-day MA of 0.03, and above the 200-day MA of 0.04, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 56.31 is Neutral, neither overbought nor oversold. The STOCH value of 28.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:AHF.
Australian Dairy Nutritionals Group Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | AU$142.78M | 7.66 | 10.01% | 2.19% | 38.25% | 361.54% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | AU$89.41M | 17.11 | 13.97% | ― | 28.66% | ― | |
51 Neutral | AU$1.80B | 9.86 | 0.82% | 1.95% | 0.49% | -127.84% | |
50 Neutral | AU$28.23M | -2.06 | -41.69% | ― | 102.21% | 69.47% | |
40 Underperform | AU$26.02M | -5.27 | -19.17% | ― | 13.92% | 36.28% | |
40 Underperform | AU$30.48M | -0.37 | 19.78% | ― | 1.03% | -52.56% |
* Consumer Defensive Sector Average
AU:AHF
Australian Dairy Nutritionals Group
0.03
-0.02
-40.00%
AU:NOU
Noumi Limited
0.11
-0.03
-21.43%
AU:BGA
Bega Cheese Limited
5.89
0.65
12.32%
AU:BUB
Bubs Australia Ltd.
0.10
-0.03
-23.08%
AU:NUC
Nuchev Pty Ltd
0.18
0.00
0.00%
AU:CLV
Clover Corporation Limited
0.86
0.36
71.00%
Australian Dairy Nutritionals Group Corporate Events
Director Peter Nathan Increases Stake in Australian Dairy Nutritionals
Mar 8, 2026
Australian Dairy Nutritionals Group has disclosed a change in director Peter Nathan’s interests, with his indirect holdings increasing through on-market share purchases. The transactions, executed via entities associated with Nathan between ...
Australian Dairy Director Increases Stake via Entitlement Offer
Mar 3, 2026
Australian Dairy Nutritionals Limited has disclosed a change in director Peter Nathan’s indirect interests, reflecting his increased shareholding through entities associated with his superannuation and family accounts. The move underscores t...
Australian Dairy Nutritionals Issues Interim Half-Year Financial Report
Feb 26, 2026
Australian Dairy Nutritionals Group has released its interim financial report for the half year ended 31 December 2025, detailing its financial performance, position, and cash flows over the period. The report, which includes directors’ comm...
Australian Dairy Nutritionals Seeks ASX Quotation for 19.1 Million New Shares
Feb 25, 2026
Australian Dairy Nutritionals Limited has applied for quotation on the ASX of 19,109,443 new fully paid ordinary shares under its existing issuer code AHF. The new securities, issued on 25 February 2026 and linked to a previously announced transac...
Australian Dairy Nutritionals Completes Entitlement Offer, Retains Shortfall Placement Option
Feb 25, 2026
Australian Dairy Nutritionals Limited has completed its 1-for-6 pro rata non-renounceable entitlement offer, issuing 19,109,443 new shares and raising about $535,000 before costs, with total shares on issue increasing to 762,431,258. The company w...
Australian Dairy Nutritionals Limits $3.5m Entitlement Offer to Core Regional Investors
Feb 3, 2026
Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer of fully paid ordinary shares at $0.028 per share to raise approximately $3.47 million, available only to shareholders with registered address...
Australian Dairy Nutritionals Launches A$3.47m Entitlement Offer at Discounted Issue Price
Feb 3, 2026
Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer to raise approximately A$3.47 million through the issue of new fully paid ordinary shares at A$0.028 per share to eligible shareholders on the...
Australian Dairy Nutritionals Launches $3.5m Entitlement Offer With Limits on Control Shift
Jan 27, 2026
Australian Dairy Nutritionals Limited has launched a 1-for-6 pro rata non-renounceable entitlement offer of fully paid ordinary shares at $0.028 per share to raise approximately $3.47 million. Eligible shareholders on the 30 January 2026 record da...
Australian Dairy Nutritionals Plans Large Pro Rata Share Issue
Jan 27, 2026
Australian Dairy Nutritionals Limited has announced a proposed non-renounceable pro rata issue of up to 123,886,970 fully paid ordinary shares, with an ex-date of 29 January 2026, a record date of 30 January 2026, and an expected issue date of 25 ...
Australian Dairy Nutritionals Launches A$3.47m Entitlement Offer to Fund China Growth and Efficiency Upgrades
Jan 27, 2026
Australian Dairy Nutritionals Limited has launched a pro-rata non-renounceable entitlement offer to raise approximately A$3.47 million by issuing up to 123.9 million new shares at A$0.028 each, allowing eligible shareholders in Australia, New Zeal...
Australian Dairy Nutritionals Shares Halted Pending Material Capital Raising
Jan 21, 2026
Australian Dairy Nutritionals Limited has requested and been granted a trading halt on its securities on the ASX while it prepares an announcement regarding a proposed capital raising. The company has indicated that the capital raising will be mat...
Australian Dairy Nutritionals Boosts China Powder Sales but Vietnam Setback Drags Quarterly Revenue
Jan 21, 2026
Australian Dairy Nutritionals Group reported Q2 FY26 consolidated revenue of $1.4 million, with nutritional powder sales of $776,000 up 152% on the prior corresponding period, driven by expanded distribution of its Future brand in China and contra...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.